Sanofi’s Dupixent Has Greater Benefit In COPD Patients With Higher Type II Inflammation

Full Pivotal Data Suggests

 
• By Ayisha Sharma
  
Man in polluted city holding a face mask over his face
Air Pollution Is One Of The Causes of COPD • Source: Shutterstock

More from Clinical Trials

More from R&D